Bloomberg: The "extremely fervent period" emerges as small companies flock to the AI boom
BlockBeats news, on May 8, according to Bloomberg, a small pharmaceutical company, which was even at risk of being delisted from the Nasdaq stock trading platform, celebrated a new cancer treatment patent and rapidly transformed into an AI company within just two months. This move, to some extent (though only briefly), helped save its stock price.
The company is named Qualigen Therapeutics, and has now been renamed to a certain exchange, trading under the stock code AIXC. After the renaming, its stock price more than doubled in late September.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic's Path to the Public Markets Just Got 2 New Developments
WLD’s 15% price surge follows World Network’s launch of ‘World Money’ Super App
In the coming month, you will see bitcoin prices starting with '10', or even double eleven!
Meta (META.US) data center's first high-yield bond is oversubscribed more than four times, strong demand drives premium issuance
The first junk bond issuance by the data center division of Meta Platforms attracted demand over four times the transaction size, with its enticing yields drawing in investors.
